Who are Magnesium glucoheptonate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Mg Oxide.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/magnesium-glucoheptonate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Magnesium glucoheptonate — Competitive Intelligence Brief

Magnesium glucoheptonate (Magnesium glucoheptonate) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Magnesium supplement. Area: Nutritional/Metabolic.

marketed Magnesium supplement Nutritional/Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Magnesium glucoheptonate (Magnesium glucoheptonate) — Scarborough General Hospital. Magnesium glucoheptonate is an oral magnesium supplement that provides bioavailable magnesium ions to correct magnesium deficiency and support normal cellular and enzymatic function.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Magnesium glucoheptonate TARGET	Magnesium glucoheptonate	Scarborough General Hospital	marketed	Magnesium supplement
Mg Oxide	Mg Oxide	Shiraz University of Medical Sciences	marketed	Osmotic laxative; magnesium supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Magnesium supplement class)

Scarborough General Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Magnesium glucoheptonate — Competitive Intelligence Brief. https://druglandscape.com/ci/magnesium-glucoheptonate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab